Bryan, Garnier & Co's News

Novo Nordisk: How competitive will all degludec-based products be in the US?

NEUTRAL, Fair Value DKK390 (+5%)
News published on
September Tuesday 29, 2015



For more information, please contact marketing@bryangarnier.com